Aragen licenses a protein technology to speed up biologics R&D

CRO Aragen Biosciences signed a deal with Dutch service provider ProteoNic Biotechnology to get its hands on a protein-production technology it believes can improve biologics development. The platform, called 2G UNic, is designed to make protein manufacturing cheaper and more efficient, Aragen said. Under the agreement, Aragen will pay an undisclosed fee to offer ProteoNic's technology to its clients, and the CRO is not on the hook for royalties. More

Suggested Articles

WuXi AppTec has cut the ribbon on its expanded Laboratory Testing Division in New Jersey as it looks to boost its integrated testing service portfolio.

St. Jude, Microsoft and DNAnexus have created a data-sharing and analysis platform to help accelerate pediatric cancer research.

The money will be used to expand its footprint in both China and the U.S., including a new R&D operation in Boston.